Dr. Vogenberg on Regulatory and Legislative Changes Effect on Healthcare, P&T Committees

AMI founding partner Dr. Randy Vogenberg recently co-authored an article for Pharmacy & Therapeutics (P&T)’s January 2018 issue entitled “Regulatory Change Versus Legislation Impacting Health Care Decisions and Delivery”.  The article explores high-level trends of the Trump administration’s policy, legislative agenda, and regulations, focusing on FDA policies that may affect drug prices and relaxation of the Patient Protectionand Affordable Care Act of 2010 (PPACA).

The article goes into the effects these changes, which have often been done in an unprecedented manner, may have on the marketplace, health care organizations, and P&T committees.

Read the article online at P&T Community here.

Download a PDF of the article here.